Condition (MeSH)
Placental Insufficiency
ClinicalTrials.gov lists 23 trials for Placental Insufficiency or a narrower condition beneath it. Les Laboratoires des Médicaments Stériles has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
23 of the 23 trials are tagged with Placental Insufficiency itself; the rest are tagged with a narrower condition beneath it.
When did Placental Insufficiency trials start? (16)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 2 |
| 2024 | 1 |
| 2023 | 1 |
| 2022 | 1 |
| 2019 | 1 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 1 |
| 2013 | 2 |
Showing 10 of 16 earlier years.
No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Placental Insufficiency trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 2 |
| Not applicable | 5 |
| Observational | 13 |
How many Placental Insufficiency trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 4 |
| Completed | 13 |
| Unknown status | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Placental Insufficiency trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Les Laboratoires des Médicaments Stériles | 1 |
Which drugs are being tested for Placental Insufficiency? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| LOVENOX | 1 |
Interventions as named in the registry (12)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| EC Aspirin | 2 |
| Delayed Cord Clamping (DCC) | 1 |
| Bloodwork, baseline | 1 |
| Pravastatin Pill | 1 |
| Bloodwork, Months -1 to -6 | 1 |
Showing 5 of 12 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Placental Insufficiency? (45)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Safety of contrast-enhanced ultrasound using microbubbles in human pregnancy: A scoping review. | Ultraschall in der Medizin (Stuttgart, Germany : 1980) | 2025 | Yes |
| Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study. | The Lancet. Rheumatology | 2022 | Yes |
| Effect of delayed cord clamping on stem cell transfusion and hematological parameters in preterm infants with placental insufficiency: a pilot randomized trial. | European journal of pediatrics | 2021 | Yes |
| The duration of sexual relationship and its effects on adverse pregnancy outcomes. | Journal of reproductive immunology | 2018 | Yes |
| Revealed versus concealed criteria for placental insufficiency in an unselected obstetric population in late pregnancy (RATIO37): randomised controlled trial study protocol. | BMJ open | 2017 | Yes |
Showing 5 of 45 publications.
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Placental insufficiency | Point prevalence | 1-5 / 10 000 | Worldwide | Not stated | Exact |
| Placental insufficiency | Point prevalence | 1-5 / 10 000 | Worldwide | Not stated | Unspecified |
| Placental insufficiency | Point prevalence | 1-5 / 10 000 | Worldwide | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Placental insufficiency | 439167 | Exact | Orphadata Science knowledge files, Product 1 |
| Placental insufficiency | 439167 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.